Oxford Immunotec Global PLC (OXFD) Releases Earnings Results, Misses Expectations By $-0.01 EPS

Oxford Immunotec Global PLC (OXFD) reported quarterly earnings results on Tuesday, May-3-2016. The company reported $-0.32 earnings per share for the quarter, missing the analyst consensus estimate by $-0.01. Analysts had a consensus of $-0.31. The company posted revenue of $17.10 million in the period, compared to analysts expectations of $17.00 million. The company’s revenue was up 23.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $-0.31 EPS.

Oxford Immunotec Global PLC opened for trading at $10.56 and hit $11.465 on the upside on Monday, eventually ending the session at $11.31, with a gain of 8.13% or 0.85 points. The heightened volatility saw the trading volume jump to 28,354 shares. Company has a market cap of $255 M.

In a different news, on Nov 20, 2015, Richard A Sandberg (director) sold 5,000 shares at $13.49 per share price.

Oxford Immunotec Global PLC is a global commercial-stage diagnostics company focused on developing and commercializing tests for the management of immune-regulated conditions. The Company’s T-SPOT technology platform allows it to measure the responses of specific immune cells to inform the diagnosis prognosis and monitoring of patients with immune-regulated conditions. The Company’s development activities are focused on four areas: chronic infections transplantation autoimmune and inflammatory disease and immune-oncology. Its T-SPOT.TB test is used to test for Tuberculosis. Its T-SPOT.CMV assay is used to assess the strength of a patient’s cellular immune response to cytomegalovirus. The T-SPOT.PRT test assesses T cell responses to foreign tissue. T-SPOT.ICA assay measures the competence of T cells. The Company has three products targeting the autoimmune and inflammatory disease area: SpiroFind assay GoutiFind and Stratokine.

Oxford Immunotec Global PLC

Leave a Reply

Oxford Immunotec Global PLC - Is it time to Sell?

Top Brokerage Firms are advising their investors on Oxford Immunotec Global PLC. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.